无菌性皮肤炎,静脉血栓塞和癌症:一个队列分析
Sissel Brandt Toft Sørensen1,2, Cecilia H Fuglsang3, Erzsébet Horváth-Puhó4
1Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Journal of thrombosis and thrombolysis
|September 4, 2025
概括
皮炎和静脉血栓塞栓症患者面临隐性癌症的风险增加,特别是在诊断后的一年内. 这一发现凸显了对该患者群体潜在恶性瘤的监测的重要性.
科学领域:
- 皮肤病学
- 癌症学
- 血管医学
背景情况:
- 无菌性皮肤炎被认为是静脉血栓栓塞 (VTE) 的危险因素.
- 这可能是潜在的未诊断癌症的早期标志.
- 皮炎,静脉突发炎和随后的癌症风险之间的关联需要进一步调查.
研究的目的:
- 确定有无形性皮肤炎患者的静脉血栓栓塞是否可以作为隐性癌症的标志物.
- 在有过亚托皮性皮肤炎的个体中首次诊断VTE后,量化癌症风险.
主要方法:
- 使用丹麦卫生登记册 (1980-2022) 进行基于人口的队列研究.
- 鉴定了582名首次发生静脉突发症的患者,并有过亚托皮炎的病史.
- 计算绝对癌症风险和标准化发病率 (SIR),以死亡为竞争事件.
主要成果:
- 在VTE后的第一年观察到1. 7%的绝对癌症风险 (SIR 2. 90).
- 在随后的随访年中,总体癌症的SIR降至1. 12.
- 在阿托皮性皮肤炎患者中,建议在VTE后增加癌症风险,特别是在第一年内.
结论:
- 性皮肤炎患者的静脉血栓栓塞可能表明隐性癌症的风险增加.
- 这种癌症的风险在VTE后的第一年显得最明显.
- 由于风险估计不准确,需要对更大群体进行进一步的研究.
相关概念视频
Venous Thrombosis I: Introduction
40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
33
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
33
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Cancer Survival Analysis
445
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
445
Venous Thrombosis IV: Nursing Management
22
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
22
Varicose Veins II: Diagnostic Studies and Interprofessional Care
29
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
29


